Biocina

BioCina is a global end-to-end CDMO delivering exceptional quality, regulatory excellence, and industry-leading on-time, in-full delivery. With deep expertise in small molecules, microbial, pDNA, and mRNA, we offer cell line, process, analytical, and formulation development, plus cGMP clinical and commercial manufacturing. We operate two state-of-the-art facilities in Adelaide and Perth, led by highly experienced SMEs with an average tenure of 10+ years. Our sites are licensed by the Australian TGA and have passed inspections by the US FDA, EMA, and Health Canada. With a proven track record of supplying drug substance and sterile drug product to 98 countries, BioCina proudly serves clients across every major global market. Because we are not a drug developer, our sole focus is on advancing our clients’ products. Australia also offers one of the world’s most generous R&D tax incentives, up to 48.5% cash back, making BioCina an ideal partner for scaling and manufacturing.